New AGA report subtleties adequacy and wellbeing of fecal microbiota transplantation Kumar Jeetendra | October 4, 2020 Now, the American Gastroenterological Association (AGA) released the first results in the NIH-funded AGA Fecal Microbiota Transplantation (FMT) National Registry, the largest real world study about the effectiveness and safety of FMT. Published in Gastroenterology, the registry reported that FMT resulted in a treatment of Clostridioides difficile (C. difficile) infection in 90% of individuals across …
Polygenic threat ratings from multi-populace information should enhance IBD predictions Kumar Jeetendra | December 25, 2020 Using genetic data from nearly 30,000 individuals, Mount Sinai researchers have assembled hazard scores from a combination of datasets representing distinct ancestral populations that improve prediction of risk for inflammatory bowel diseases (IBD) including Crohn’s disease and ulcerative colitis. The research was published in Gastroenterology on December 24. The researchers found that polygenic risk scores, …
Study proposes expected role for probiotics in forestalling respiratory infections Kumar Jeetendra | May 15, 2021 Daily probiotic use was associated with fewer upper respiratory symptoms in overweight and older people, according to a study which suggests a potential role for probiotics in preventing respiratory infections. Researchers re-analyzed detailed daily diaries of 220 patients who engaged in a previous double-blind placebo-controlled study on probiotics and weight loss. Reviewing the entries for …
Scientists create stable cell lines equipped for delivering different hepatitis B virus genotypes Kumar Jeetendra | February 15, 2022 A new study has created cells that can be stable and capable to produce different strains of the Hepatitis B virus (HBV) which is helping to improve understanding of the distinctive virological characteristics treatments, virological features, and infectivity, which could lead to the development of new treatments against the virus that infects humans as long …
Here is a list of the leading 10 pharmaceutical companies in India Kumar Jeetendra | March 2, 2023 India is well-known for establishing a strong foothold in the global pharmaceutical business. It has expanded considerably in recent years. There are over 60,000 generic brands in 60 therapeutic areas. India’s Pharma companies generate about 500 different active pharmaceutical ingredients (APIs). Over 50% of Africa’s need for generic drugs is met by India, as is …
